Mike Hsu

Kimberly-Clark Appoints Former Walgreens, Kraft Heinz Exec as Chief Information & Global Business Services Officer

by | Mar 11, 2026
Francesco Tinto, who has over 30 years of experience in technology leadership, will oversee Irving-based Kimberly-Clark's information technology and GBS organizations. 
MORE
Shareholders Approve Kimberly-Clark’s $40B Acquisition of Tylenol Maker Kenvue
by | Jan 29, 2026
Kimberly-Clark Chairman and CEO Mike Hsu said the milestone "advances our efforts to create a preeminent global health and wellness leader that will raise the standard of care for billions of people around the world and generate significant value for shareholders."
MORE
North Texas’ Kimberly-Clark To Acquire Tylenol Maker in $40B Deal
by | Nov 3, 2025
New Jersey-based Kenvue—which spun off from Johnson & Johnson in 2023—is the maker of Tylenol, whose active ingredient, acetaminophen, has been linked to autism by the Trump administration. Kimberly-Clark CEO Mike Hsu says the unique combination of CPG and healthcare brands "will serve billions of consumers across every stage of life."
MORE
North Texas’ Kimberly-Clark Sells Majority Stake in Its Int’l Tissue Business to Brazil’s Suzano for $1.73B
by | Jun 5, 2025
Irving-based Kimberly-Clark will maintain a 49% interest in the new joint venture, which is valued at $3.4 billion. The company said it is sharpening its focus on its "higher growth, higher margin businesses."
MORE